Cargando…
Pharmacological rescue of impaired mitophagy in Parkinson’s disease-related LRRK2 G2019S knock-in mice
Parkinson’s disease (PD) is a major and progressive neurodegenerative disorder, yet the biological mechanisms involved in its aetiology are poorly understood. Evidence links this disorder with mitochondrial dysfunction and/or impaired lysosomal degradation – key features of the autophagy of mitochon...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8331189/ https://www.ncbi.nlm.nih.gov/pubmed/34340748 http://dx.doi.org/10.7554/eLife.67604 |
_version_ | 1783732868734779392 |
---|---|
author | Singh, Francois Prescott, Alan R Rosewell, Philippa Ball, Graeme Reith, Alastair D Ganley, Ian G |
author_facet | Singh, Francois Prescott, Alan R Rosewell, Philippa Ball, Graeme Reith, Alastair D Ganley, Ian G |
author_sort | Singh, Francois |
collection | PubMed |
description | Parkinson’s disease (PD) is a major and progressive neurodegenerative disorder, yet the biological mechanisms involved in its aetiology are poorly understood. Evidence links this disorder with mitochondrial dysfunction and/or impaired lysosomal degradation – key features of the autophagy of mitochondria, known as mitophagy. Here, we investigated the role of LRRK2, a protein kinase frequently mutated in PD, in this process in vivo. Using mitophagy and autophagy reporter mice, bearing either knockout of LRRK2 or expressing the pathogenic kinase-activating G2019S LRRK2 mutation, we found that basal mitophagy was specifically altered in clinically relevant cells and tissues. Our data show that basal mitophagy inversely correlates with LRRK2 kinase activity in vivo. In support of this, use of distinct LRRK2 kinase inhibitors in cells increased basal mitophagy, and a CNS penetrant LRRK2 kinase inhibitor, GSK3357679A, rescued the mitophagy defects observed in LRRK2 G2019S mice. This study provides the first in vivo evidence that pathogenic LRRK2 directly impairs basal mitophagy, a process with strong links to idiopathic Parkinson’s disease, and demonstrates that pharmacological inhibition of LRRK2 is a rational mitophagy-rescue approach and potential PD therapy. |
format | Online Article Text |
id | pubmed-8331189 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-83311892021-08-04 Pharmacological rescue of impaired mitophagy in Parkinson’s disease-related LRRK2 G2019S knock-in mice Singh, Francois Prescott, Alan R Rosewell, Philippa Ball, Graeme Reith, Alastair D Ganley, Ian G eLife Cell Biology Parkinson’s disease (PD) is a major and progressive neurodegenerative disorder, yet the biological mechanisms involved in its aetiology are poorly understood. Evidence links this disorder with mitochondrial dysfunction and/or impaired lysosomal degradation – key features of the autophagy of mitochondria, known as mitophagy. Here, we investigated the role of LRRK2, a protein kinase frequently mutated in PD, in this process in vivo. Using mitophagy and autophagy reporter mice, bearing either knockout of LRRK2 or expressing the pathogenic kinase-activating G2019S LRRK2 mutation, we found that basal mitophagy was specifically altered in clinically relevant cells and tissues. Our data show that basal mitophagy inversely correlates with LRRK2 kinase activity in vivo. In support of this, use of distinct LRRK2 kinase inhibitors in cells increased basal mitophagy, and a CNS penetrant LRRK2 kinase inhibitor, GSK3357679A, rescued the mitophagy defects observed in LRRK2 G2019S mice. This study provides the first in vivo evidence that pathogenic LRRK2 directly impairs basal mitophagy, a process with strong links to idiopathic Parkinson’s disease, and demonstrates that pharmacological inhibition of LRRK2 is a rational mitophagy-rescue approach and potential PD therapy. eLife Sciences Publications, Ltd 2021-08-03 /pmc/articles/PMC8331189/ /pubmed/34340748 http://dx.doi.org/10.7554/eLife.67604 Text en © 2021, Singh et al https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Cell Biology Singh, Francois Prescott, Alan R Rosewell, Philippa Ball, Graeme Reith, Alastair D Ganley, Ian G Pharmacological rescue of impaired mitophagy in Parkinson’s disease-related LRRK2 G2019S knock-in mice |
title | Pharmacological rescue of impaired mitophagy in Parkinson’s disease-related LRRK2 G2019S knock-in mice |
title_full | Pharmacological rescue of impaired mitophagy in Parkinson’s disease-related LRRK2 G2019S knock-in mice |
title_fullStr | Pharmacological rescue of impaired mitophagy in Parkinson’s disease-related LRRK2 G2019S knock-in mice |
title_full_unstemmed | Pharmacological rescue of impaired mitophagy in Parkinson’s disease-related LRRK2 G2019S knock-in mice |
title_short | Pharmacological rescue of impaired mitophagy in Parkinson’s disease-related LRRK2 G2019S knock-in mice |
title_sort | pharmacological rescue of impaired mitophagy in parkinson’s disease-related lrrk2 g2019s knock-in mice |
topic | Cell Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8331189/ https://www.ncbi.nlm.nih.gov/pubmed/34340748 http://dx.doi.org/10.7554/eLife.67604 |
work_keys_str_mv | AT singhfrancois pharmacologicalrescueofimpairedmitophagyinparkinsonsdiseaserelatedlrrk2g2019sknockinmice AT prescottalanr pharmacologicalrescueofimpairedmitophagyinparkinsonsdiseaserelatedlrrk2g2019sknockinmice AT rosewellphilippa pharmacologicalrescueofimpairedmitophagyinparkinsonsdiseaserelatedlrrk2g2019sknockinmice AT ballgraeme pharmacologicalrescueofimpairedmitophagyinparkinsonsdiseaserelatedlrrk2g2019sknockinmice AT reithalastaird pharmacologicalrescueofimpairedmitophagyinparkinsonsdiseaserelatedlrrk2g2019sknockinmice AT ganleyiang pharmacologicalrescueofimpairedmitophagyinparkinsonsdiseaserelatedlrrk2g2019sknockinmice |